Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00347620
Other study ID # 2000-072
Secondary ID
Status Completed
Phase N/A
First received June 30, 2006
Last updated March 12, 2010
Start date August 2000
Est. completion date December 2003

Study information

Verified date March 2010
Source University of Alabama at Birmingham
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

The primary purpose of this study is to evaluate whether interventions to improve vision in nursing home residents have an impact on residents' health-related quality of life. The interventions being evaluated are correction of refractive error (near-sightedness, far-sightedness, presbyopia) and cataract surgery.


Description:

The purpose of this project is two-fold: 1.) to establish the psychometric properties of the Nursing Home Vision-Specific Health-Related Quality of Life (HRQOL) instrument, and; 2.) to evaluate the responsiveness of this instrument. Responsiveness will be assessed in two independent preliminary prospective intervention evaluations. The first responsiveness evaluation will involve a new spectacle intervention and the second will involve first eye cataract surgery. In addition, we will examine the association between the responsiveness of this instrument, and changes in visual functioning measures and other demographic variables.


Recruitment information / eligibility

Status Completed
Enrollment 400
Est. completion date December 2003
Est. primary completion date
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 60 Years and older
Eligibility Inclusion Criteria:

- at least 60 years of age or older

- expected to stay in facility foe at least 8 months

- stable medical condition

- moderately cognitively impaired or better

Exclusion Criteria:

- those not meeting inclusion criteria

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Device:
spectacles

Procedure:
Cataract Surgery


Locations

Country Name City State
United States Integrated Health Services at Briarcliff Alabaster Alabama
United States Shelby Ridge Nursing Home Alabaster Alabama
United States Beverly Healthcare Meadowood Bessemer Alabama
United States Livingston Health Care Center Bessemer Alabama
United States Southgate Village Bessemer Alabama
United States Beverly Healthcare Center Forestdale Birmingham Alabama
United States Beverly Healthcare East Birmingham Alabama
United States Beverly Healthcare Riverchase Birmingham Alabama
United States Estes Nursing Facility Civic Center Birmingham Alabama
United States Estes Nursing Facility Northway Birmingham Alabama
United States Fair Haven Retirement Center Birmingham Alabama
United States Fairview Health & Rehabilitation Center Birmingham Alabama
United States South Haven Birmingham Alabama
United States Beverly Health Care Center West Fairfield Alabama
United States The Self Nursing Home, Inc Hueytown Alabama
United States Beverly Healthcare Pleasant Grove Pleasant Grove Alabama
United States Consult America Cottage Hills Pleasant Grove Alabama

Sponsors (7)

Lead Sponsor Collaborator
University of Alabama at Birmingham EyeSight Foundation of Alabama, National Eye Institute (NEI), National Institute on Aging (NIA), Pearle Vision Foundation, Research to Prevent Blindness, Retirement Research Foundation

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary vision-targeted health-related quality of life
Secondary depression
Secondary generic health-related quality of life
Secondary functional independence
Secondary participation in group activities
Secondary physical activities
Secondary falls
Secondary life space
See also
  Status Clinical Trial Phase
Completed NCT04685538 - Chloroprocaine 3% Gel Eye Drop as Topical Anestheticsin Phacoemulsification. Phase 3
Recruiting NCT06060041 - IC-8 Apthera IOL New Enrollment Post Approval Study
Recruiting NCT05518539 - Evaluation of Quality of Vision and Visual Outcomes With Bilateral Implantation of the Clareon PanOptix Intraocular Lens
Recruiting NCT05271942 - Tilt and Tumble vs Divide and Conquer - a Unique Comparison of the Two Cataract Surgery Methods N/A
Active, not recruiting NCT04778501 - PMCF Study on Monofocal Toric IOL (PODEYE TORIC) in Asia N/A
Completed NCT05062564 - Efficacy of LipiFlow in Patients Affected by Meibomian Gland Dysfunction in Reducing Post-cataract Surgery Dry Eye N/A
Completed NCT03751033 - Influence of DisCoVisc Ophthalmic Viscosurgical Device (OVD) on Intraoperative Aberrometry Readings N/A
Completed NCT02529488 - Investigation of AcrySof® IQ PanOptix™ Presbyopia-Correcting Intraocular Lens (IOL) Model TFNT00 N/A
Completed NCT04539548 - A Study Assessing the Safety and Efficacy of Dextenza® for the Treatment of Ocular Pain and Inflammation Following Surgery for Pediatric Cataract Phase 3
Completed NCT03740659 - Evaluation Of Aqueous Humor Of Levofloxacin-Dexamethasone Eye Drops And Of Its Components In Patients Undergoing Cataract Surgery Phase 2
Completed NCT03494257 - Effect of Fixed Brinzolamide-brimonidine Combination on Intraocular Pressure After Phacoemulsification N/A
Completed NCT05119127 - Rotational Stability of Acrysof IQ Vivity Extended Vision Toric IOL and Refractive Visual Outcome. N/A
Active, not recruiting NCT04271709 - Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT) N/A
Recruiting NCT03713268 - Intraoperative OCT Guidance of Intraocular Surgery II
Completed NCT03739528 - Levo-Dexa vs. Tobra+Dexa for Prevention and Treatment of Inflammation and Prevention of Infection in Cataract Surgery Phase 3
Completed NCT02888210 - A Study Assessing Safety and Efficacy of MD-15 Intraocular Lens in Patients With Aphakic Eye After Cataract Surgery Phase 3
Completed NCT03356847 - Evaluation of the Rotational Stability of the Monofocal SISA Implant Following Cataract Surgery N/A
Completed NCT04332640 - Clinical Evaluation of the Next Generation Phaco System N/A
Recruiting NCT03638726 - Subconjunctival Atropine and Intracameral Epinephrine for Pupil Dilation in Phacoemulsification Phase 4
Completed NCT03050697 - Evaluation of the Safety and Performance of the HARMONI® Toric Lens N/A